Infectious diseases & vaccines

  1. Home
  2. Infectious diseases & vaccines

Janssen Infectious Diseases & Vaccines

Infectious diseases account for 15% of all deaths worldwide each year.1 Therefore, we at Janssen are committed to the fight against infectious diseases; from viral hepatitis and human immunodeficiency virus (HIV) to pathogens of global concern. We strive to discover and develop novel therapeutics and vaccines to help prevent, treat, improve treatment outcomes and ultimately healing of infectious diseases worldwide, thereby improving the lives of patients.

Our areas of focus for infectious diseases

Make HIV History

Building on our 25-year commitment to make HIV history, we aim to change the course of the epidemic through our passionate pursuit of innovative treatment, for the long-term remission from HIV, to effective prevention. The pursuit of a preventive HIV vaccine continues Janssen’s pioneering legacy in providing life-saving HIV medicines.
Discover more

Respiratory Infections

At Janssen, we have a deep heritage of caring for those affected by respiratory infections. We combine our passion with innovative science to reduce the serious impact of respiratory infections including COVID-19, RSV and influenza.
Discover more

Hepatitis B

There are nearly 300 million people chronically infected with hepatitis B today. Of the fewer than 20% of patients who know they have the disease, only approximately 5% get treatment.2,3,4 This results in approximately one death every 30 seconds worldwide due to hepatitis B infection, mostly from complications including cirrhosis and hepatocellular carcinoma.3
Discover more

Bacterial infections

We are prioritizing development of vaccines to protect people against bacterial infections, and exploring innovative technologies to treat those infected. Through new scientific approaches, we aim to reduce the potentially devastating consequences of bacterial diseases, dependency on antibiotics and, ultimately, the risk of antimicrobial resistance (AMR) and multidrug resistance (MDR).
Discover more

COVID-19 related news

Supporting materials

PubMed tool

Are you looking for a recent article and bibliographical references on a specific topic in your field? Then we are happy to help you based on the extensive database of PubMed Central.
Discover more

3D simulator

On this page you will find interactive 3D animations of the human anatomy and various syndromes. This allows you to zoom in on the anatomy, tissue structures, disease mechanisms and the course of the disease.
Discover more

Magazines

Bekijk en download hier

Interviews (in Dutch)

Graag nemen we u mee in een relevant onderwerp in de hiv-zorg, namelijk de ‘late presenters’, ook wel ‘late diagnoses’ genoemd. Zij maken ongeveer de helft uit van het aantal nieuwe hiv-diagnoses per jaar.  
Discover more

 

 

References

  1. World Health Organisation. Projections of mortality and causes of death, 2016 to 2060 – Global summary projections. Available at: https://www.who.int/healthinfo/global_burden_disease/projections/en/. Last accessed: October 2019.
  2. World Health Organization (WHO). Hepatitis B. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/. Last accessed: October 2019.
  3. Lazarus J et al. The hepatitis B epidemic and the urgent need for cure preparedness. Nat Rev Gastro Hepat. 2018;15(9): 517-518.
  4. Hepatitis B Foundation. Hepatitis B fast facts. Available at: http://www.hepb.org/assets/Uploads/Hepatitis-B-Fast-Facts-8-28-18-FINAL.pdf. Last accessed: December 2019

 

CP-197007 - 01-Dec-2020